Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Claud B who wrote (717)	11/9/1997 5:33:00 PM
From: Bradpalm1	Read Replies (2) \| Respond to of 7041

Claud, How do you account for the discrepancy of these facts? I would seriously question the motives of this companies management if false information were being disseminated to investors. Further, what was Dr. Goldstein's real role when he was hired as a consultant by Zonagen last summer? I heard it said that he changed the direction of ongoing clinical trials at that time so that the responses of men with 'minimal ED' were measured and published instead of the original group with 'organic ED'. This was supposedly to assure Zonagen of 'positive' results at that critical time. Could you please comment. Bradpalm1